Alkermes is a fully integrated, global biopharmaceutical company that focuses on developing innovative medicines in the field of neuroscience to address serious mental illness, addiction, and cancer. They apply scientific expertise and proprietary technology to enhance their offerings as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO).

Services include:
- Finished Dosage Forms
- Biologics

Alkermes continues to deliver high-quality solutions within the pharmaceutical industry, emphasising their commitment to innovation and excellence. Readers can find more information at alkermes.com.